TELA Bio (TELA) Change in Intangibles (2019)

TELA Bio (TELA) recorded quarterly Change in Intangibles of $2.0 million in Q3 2019, up 300.0% quarter-over-quarter from $500000.0 in Q1 2019.

TELA Bio (TELA) Change in Intangibles (2019) Analysis & Trends

TELA Bio's Change in Intangibles history runs 1 years deep, the most recent figure standing at $2.0 million for Q3 2019.

In Q3 2019, Change in Intangibles changed N/A year-over-year to $2.0 million; the TTM figure through Dec 2019 stood at $2.5 million (changed N/A YoY), while the FY2022 annual figure was $1.0 million, changed N/A from the prior year.
Change in Intangibles was $2.0 million for Q3 2019 at TELA Bio, up from $500000.0 in the prior quarter.
In the past five years, Change in Intangibles ranged from a high of $2.0 million in Q3 2019 to a low of $500000.0 in Q1 2019.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Change in Intangibles (Qtr)
1	Abbott Laboratories	152.92 Bn	146.27 Bn	6.27 Bn	-
2	Stryker	119.50 Bn	116.62 Bn	3.81 Bn	-
3	Medtronic	102.71 Bn	94.54 Bn	5.76 Bn	-
4	Boston Scientific	69.72 Bn	68.51 Bn	3.61 Bn	-
5	Edwards Lifesciences	49.24 Bn	45.57 Bn	1.29 Bn	-
6	GE HealthCare Technologies	29.74 Bn	27.67 Bn	1.98 Bn	-
7	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn	-31.61 Mn
8	Dexcom	28.96 Bn	27.84 Bn	750.30 Mn	-
9	Steris	20.31 Bn	19.88 Bn	697.10 Mn	-
10	TELA Bio	49.36 Mn	9.81 Mn	12.52 Mn	-

Download Data